A CT imaging-based deep learning model for predicting EGFR and KRAS mutations in non-small cell lung cancer: toward personalized treatment approaches

Junxian Li; Yuchen Xing; Ximin Gao; Zhaoxiang Ye; Meng Wang; Fengju Song

doi:10.21037/tlcr-2025-1043

January 1, 2026Translational Lung Cancer ResearchOpen Access

A CT imaging-based deep learning model for predicting EGFR and KRAS mutations in non-small cell lung cancer: toward personalized treatment approaches

View Full Paper

Ask AI

Bookmark

Share

Key Points

The LG-MutaNet predicts EGFR and KRAS mutations with high precision in non-small cell lung cancer patients.
It uses a deep learning model, integrating clinical variables and CT imaging for accurate mutation forecasts.
This technology supports advancing personalized treatment strategies, fostering a more tailored healthcare approach.
The findings may enhance decision-making in lung cancer treatment, although further validation is required.

Implication

Observational analysis reveals successful prediction of EGFR and KRAS mutations in NSCLC, suggesting improved personalized treatment decisions.

Abstract

The LG-MutaNet, combining CT imaging and clinical variables, offers a non-invasive and precise approach for predicting EGFR and KRAS mutations in NSCLC patients, supporting personalized treatment decisions and advancing precision medicine.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Li et al. (2026) studied this question.

synapsesocial.com/papers/69a75aa8c6e9836116a20c21 https://doi.org/10.21037/tlcr-2025-1043

View Full Paper

Ask AI

Bookmark

Share

A CT imaging-based deep learning model for predicting EGFR and KRAS mutations in non-small cell lung cancer: toward personalized treatment approaches

Key Points

Implication

Abstract

Discussion

Cite This Study

A CT imaging-based deep learning model for predicting EGFR and KRAS mutations in non-small cell lung cancer: toward personalized treatment approaches

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

More from Translational Lung Cancer Research

Keep reading

More from Translational Lung Cancer Research